Xiaoli Xu

2.7k total citations
87 papers, 2.1k citations indexed

About

Xiaoli Xu is a scholar working on Molecular Biology, Computational Theory and Mathematics and Immunology. According to data from OpenAlex, Xiaoli Xu has authored 87 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 18 papers in Computational Theory and Mathematics and 15 papers in Immunology. Recurrent topics in Xiaoli Xu's work include Heat shock proteins research (23 papers), Computational Drug Discovery Methods (18 papers) and interferon and immune responses (7 papers). Xiaoli Xu is often cited by papers focused on Heat shock proteins research (23 papers), Computational Drug Discovery Methods (18 papers) and interferon and immune responses (7 papers). Xiaoli Xu collaborates with scholars based in China, Poland and United Kingdom. Xiaoli Xu's co-authors include Qidong You, Lei Wang, Haopeng Sun, Xiaojin Zhang, Zhengyu Jiang, Xiaoke Guo, Lili Xu, Li Li, Han Zhang and Mengchen Lu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaoli Xu

84 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Xu China 28 1.5k 448 309 247 218 87 2.1k
Gyoonhee Han South Korea 30 1.5k 1.0× 886 2.0× 263 0.9× 82 0.3× 474 2.2× 123 2.8k
Sheng Jiang China 27 1.2k 0.8× 475 1.1× 288 0.9× 64 0.3× 307 1.4× 77 2.1k
Sonia Lobo Planey United States 15 807 0.6× 297 0.7× 171 0.6× 281 1.1× 255 1.2× 26 1.7k
Yong Xia China 27 903 0.6× 199 0.4× 286 0.9× 57 0.2× 568 2.6× 77 2.0k
Yuepiao Cai China 25 827 0.6× 351 0.8× 203 0.7× 75 0.3× 139 0.6× 66 1.7k
Jinliang Yang China 29 1.3k 0.9× 745 1.7× 276 0.9× 57 0.2× 566 2.6× 109 2.7k
Philippe Delcourt France 29 1.3k 0.9× 325 0.7× 118 0.4× 36 0.1× 238 1.1× 40 2.4k
Adrienne L. Edkins South Africa 24 902 0.6× 249 0.6× 207 0.7× 68 0.3× 332 1.5× 91 1.7k
Alessandra Tosco Italy 25 1.0k 0.7× 175 0.4× 160 0.5× 77 0.3× 159 0.7× 75 1.6k

Countries citing papers authored by Xiaoli Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Xu more than expected).

Fields of papers citing papers by Xiaoli Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Xu. The network helps show where Xiaoli Xu may publish in the future.

Co-authorship network of co-authors of Xiaoli Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Xu. A scholar is included among the top collaborators of Xiaoli Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Xu. Xiaoli Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Xu, Xiaoli, et al.. (2025). Analysis of risk factors contributing to neonatal pneumonia in low birth weight neonates. Frontiers in Pediatrics. 13. 1620077–1620077.
4.
Xia, Ping, et al.. (2024). USP9X/HOXA1 Contributes to the Cisplatin-Resistentance of Oral Squamous Cell Carcinoma in vitro and in vivo. International Journal of Pharmacology. 20(6). 1051–1062. 2 indexed citations
5.
Zhou, Yuqiu, Yongcong Cai, Ronghao Sun, et al.. (2024). The updated surgical steps of gasless transaxillary endoscopic thyroidectomy with neck level and region orientation for thyroid cancer. Frontiers in Oncology. 14. 1377878–1377878. 1 indexed citations
6.
Li, Hui, et al.. (2024). Protein-protein interactions in cGAS-STING pathway: a medicinal chemistry perspective. Future Medicinal Chemistry. 16(17). 1801–1820. 2 indexed citations
7.
Wu, Yueheng, Xiaoli Xu, Yong Zhang, et al.. (2022). Identification and characterization of novel elastin gene mutations in eleven families with supravalvular aortic stenosis. Frontiers in Genetics. 13. 1059640–1059640. 4 indexed citations
8.
Zheng, Ying, Xiaoli Xu, Jian Liu, et al.. (2022). Atypical deletion of Williams–Beuren syndrome reveals the mechanism of neurodevelopmental disorders. BMC Medical Genomics. 15(1). 79–79. 9 indexed citations
9.
Dai, Wei‐Min, et al.. (2022). Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors. European Journal of Medicinal Chemistry. 244. 114791–114791. 27 indexed citations
10.
Chen, Xuetao, Fanying Meng, Jingtian Zhang, et al.. (2022). Discovery of 2-((2-methylbenzyl)thio)-6-oxo-4-(3,4,5-trimethoxyphenyl)-1,6-dihydropyrimidine-5-carbonitrile as a novel and effective bromodomain and extra-terminal (BET) inhibitor for the treatment of sepsis. European Journal of Medicinal Chemistry. 238. 114423–114423. 10 indexed citations
11.
Xu, Xiaoli, et al.. (2020). Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/-catenin signaling pathway in oral squamous cell carcinoma. Acta Biochimica et Biophysica Sinica. 52(5). 527–535. 13 indexed citations
12.
Wang, Lei, Xiaoli Xu, Zhengyu Jiang, & Qidong You. (2020). Modulation of protein fate decision by small molecules: targeting molecular chaperone machinery. Acta Pharmaceutica Sinica B. 10(10). 1904–1925. 27 indexed citations
13.
Wang, Lei, Lixiao Zhang, Li Li, et al.. (2019). Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer. Science Advances. 5(9). eaax2277–eaax2277. 79 indexed citations
14.
Li, Dong‐Dong, Weilin Chen, Zhihui Wang, et al.. (2016). High-affinity small molecular blockers of mixed lineage leukemia 1 (MLL1)-WDR5 interaction inhibit MLL1 complex H3K4 methyltransferase activity. European Journal of Medicinal Chemistry. 124. 480–489. 39 indexed citations
15.
Wei, Jinlian, Yingrui Yang, Yali Li, et al.. (2016). Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential. Bioorganic & Medicinal Chemistry. 25(6). 1737–1746. 16 indexed citations
16.
Sun, Haopeng, et al.. (2016). Synthesis and evaluation of 4-(2-hydroxypropyl)piperazin-1-yl) derivatives as Hsp90 inhibitors. Bioorganic & Medicinal Chemistry. 24(11). 2423–2432. 7 indexed citations
17.
Wang, Lei, Li Li, Weitao Fu, et al.. (2016). Optimization and bioevaluation of Cdc37-derived peptides: An insight into Hsp90-Cdc37 protein-protein interaction modulators. Bioorganic & Medicinal Chemistry. 25(1). 233–240. 19 indexed citations
18.
Xu, Xiaoli, Yue Wu, Mingyang Hu, et al.. (2016). Novel Natural Product-like Caged Xanthones Bearing a Carbamate Moiety Exhibit Antitumor Potency and Anti-Angiogenesis Activity In vivo. Scientific Reports. 6(1). 35771–35771. 23 indexed citations
19.
Jia, Jianmin, Fang Liu, Xiaoli Xu, et al.. (2014). Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold. Bioorganic & Medicinal Chemistry Letters. 24(6). 1557–1561. 5 indexed citations
20.
Xu, Xiaoli, et al.. (2001). Seasonality of growth in Shanghai infants (n=4128) born in 11 consecutive years. European Journal of Clinical Nutrition. 55(8). 714–725. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gyoonhee Han Breakdown of academic impact, for papers by Sheng Jiang Breakdown of academic impact, for papers by Sonia Lobo Planey Breakdown of academic impact, for papers by Yong Xia Breakdown of academic impact, for papers by Yuepiao Cai Breakdown of academic impact, for papers by Jinliang Yang Breakdown of academic impact, for papers by Philippe Delcourt Breakdown of academic impact, for papers by Adrienne L. Edkins Breakdown of academic impact, for papers by Alessandra Tosco
Rankless by CCL
2026